Fortress Biotech Cash Flow Statement (2010-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Jun2026
Operating Activities
Net Income (Quarter)	-45.47M	-54.23M	-59.85M	-49.48M	-53.93M	-53.06M	-57.45M	-62.13M	-55.81M	-10.68M	-28.96M	-38.34M	-29.18M	-26.73M	-26.32M	-25.28M	-39.06M	8.83M	-6.01M	0.60M
Depreciation and Depletion (Quarter)	0.60M	0.70M	0.73M	0.70M	0.80M	0.80M	0.80M	0.84M	0.80M	0.40M	0.30M	0.38M	0.40M	0.10M	0.14M	0.13M	0.10M	0.10M	0.10M	0.10M
Share-based Compensation (Quarter)	4.35M	4.33M	-12.24M	5.56M	5.08M	6.84M	5.51M	4.73M	4.22M	0.40M	3.70M	400.00M	5.00M	0.60M	16.19M	6.29M	16.79M		2.46M	2.88M
Cash from Discontinued Operations (Quarter)
Gains from Investment Securities (Quarter)
Asset Writedowns and Impairment (Quarter)	-0.13M	-0.01M	0.12M	-0.08M	0.03M	0.04M	0.28M	0.13M	2.80M	-2.43M	2.65M	0.01M	2.65M	0.67M	2.87M	0.20M	-0.20M	-0.17M	0.17M
Cash from Operations (Quarter)	-34.46M	-21.70M	-38.70M	-46.86M	-41.42M	-43.27M	-47.84M	-43.22M	-33.29M	-16.78M	-34.94M	-25.39M	-21.84M	-20.06M	-12.91M	-19.56M	-27.56M	-6.11M	-12.54M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	0.20M	0.72M	2.29M	0.39M	0.56M	0.10M	0.56M	0.64M	1.22M	0.66M	0.51M	0.61M	0.76M	0.39M	0.30M	0.29M	0.45M	0.32M	0.34M
Amortization of Deferred Charges (Quarter)	0.42M	0.42M	0.43M	0.44M	0.45M	0.54M	0.54M	0.52M	0.53M	0.51M	0.52M	0.53M	1.36M	0.47M	0.48M	0.48M	0.49M	0.50M	0.48M
Depreciation & Amortization (CF) (Quarter)	0.60M	0.70M	0.73M	0.70M	0.80M	0.80M	0.80M	0.84M	0.80M	0.40M	0.30M	0.38M	0.40M	0.10M	0.14M	0.13M	0.10M	0.10M	0.10M	0.10M
Change in Working Capital
Change in Receivables (Quarter)	2.05M	5.54M	-8.51M	8.00M	-2.48M	-0.08M	-0.05M	-0.47M	-10.43M	-8.83M	7.18M	-5.42M	0.81M	0.88M	-0.75M	7.99M	-2.82M	2.42M	11.76M
Change in Inventory (Quarter)	12.02M	-2.70M	-1.75M	0.23M	-0.08M	-0.82M	-1.07M	-0.88M	-1.11M	-1.14M	-0.82M	0.37M	-0.89M	2.10M	2.64M	-1.94M	0.36M	-1.03M	-2.19M
Change in Account Payables (Quarter)
Change in Accured Expenses (Quarter)	2.36M	0.22M	43.18M	-0.05M	4.24M	0.21M	-4.60M	-0.05M	-0.05M	-16.92M	16.23M	2.67M	-2.76M	-7.02M	0.73M	0.59M	-8.41M	6.31M	-6.46M
Change in Taxes (Quarter)			0.34M	0.00M	-0.00M	0.01M	0.36M		0.00M	0.08M	0.04M		-0.04M	0.04M	0.08M	0.02M	0.03M	0.02M	-0.65M
Other Working Capital Changes (Quarter)	-2.40M	-4.11M	-0.51M	-1.34M	1.31M	-1.49M	4.11M	-0.03M	-0.33M	1.47M	-0.26M	1.57M	-3.41M	-2.07M	4.53M	-2.38M	2.08M	-3.81M	3.77M
Investing Activities
Capital Expenditures (Quarter)	1.60M	0.46M	1.96M	1.34M	0.31M	-1.62M	2.69M	0.02M	0.02M	0.00M	0.03M		1.40M	-1.40M
Sales of Property, Plant and Equipment (Quarter)																1.17M
Acquisitions (Quarter)				-20.00M				-5.00M
Divestments (Quarter)																	25.10M	2.87M
Change in Acquisitions & Divestments (Quarter)
Cash from Investing Activities (Quarter)	-4.84M	-7.54M	53.35M	-21.34M	-0.31M	-0.89M	-0.39M	-5.00M	-2.04M	5.00M	-0.06M				-15.00M	1.17M	6.09M	2.87M
Financing Activities
Other financing activities (Quarter)	0.14M		0.14M				-0.10M				0.38M	0.03M			0.15M	36.00M	-35.41M	1.69M	0.37M
Cash from Financing Activities (Quarter)	24.39M	6.97M	38.94M	49.96M	2.99M	3.75M	18.62M	22.19M	-30.38M	-2.69M	43.62M	27.86M	14.27M	2.71M	25.81M	52.14M	4.52M	15.07M	5.71M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)		2.75M	6.34M	4.23M	1.30M	0.22M	0.30M	0.45M	0.72M	0.55M	-0.01M	0.89M	1.93M	0.57M	0.34M	1.01M	-0.00M
Dividend Payments
Dividends Paid - Common (Quarter)	0.19M	0.19M	0.19M	0.19M	0.19M	0.19M	0.19M	0.19M	0.18M	0.18M	0.18M	0.18M	0.18M	0.18M	0.17M	0.17M	0.17M	0.17M	0.17M
Additional items
Change in Cash (Quarter)	-14.90M	-22.27M	53.60M	-18.23M	-38.74M	-40.42M	-29.62M	-26.03M	-65.71M	-14.46M	8.62M	2.47M	-7.57M	-17.35M	-2.10M	33.74M	-16.95M	11.83M	-6.84M
Free Cash Flow (Quarter)	-36.06M	-22.16M	-40.65M	-48.20M	-41.73M	-41.65M	-50.54M	-43.24M	-33.31M	-16.78M	-34.96M	-25.39M	-23.23M	-18.66M	-12.91M	-19.56M	-27.56M	-6.11M	-12.54M
Net Cash Flow (Quarter)	-14.90M	-22.27M	53.60M	-18.23M	-38.74M	-40.42M	-29.62M	-26.03M	-65.71M	-14.46M	8.62M	2.47M	-7.57M	-17.35M	-2.10M	33.74M	-16.95M	11.83M	-6.84M

Research Tools

Datasets

Plans

Developers

Fortress Biotech FBIOP Cash Flow Statement (2010-2026)

Research Tools

Datasets

Plans

Developers

Fortress Biotech FBIOP Cash Flow Statement (2010-2026)

Create an account

Sign In

Reset Password